Your browser doesn't support javascript.
loading
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
Stewart, A Keith; Krishnan, Amrita Y; Singhal, Seema; Boccia, Ralph V; Patel, Manish R; Niesvizky, Ruben; Chanan-Khan, Asher A; Ailawadhi, Sikander; Brumm, Jochen; Mundt, Kirsten E; Hong, Kyu; McBride, Jacqueline; Shon-Nguyen, Quyen; Xiao, Yuanyuan; Ramakrishnan, Vanitha; Polson, Andrew G; Samineni, Divya; Leipold, Douglas; Humke, Eric W; McClellan, James Scott; Berdeja, Jesus G.
Afiliação
  • Stewart AK; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Stewart.Keith@mayo.edu.
  • Krishnan AY; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA.
  • Singhal S; Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • Boccia RV; Center for Cancer and Blood Disorders, Bethesda, MD, USA.
  • Patel MR; Florida Cancer Specialists, Sarasota, FL, USA.
  • Niesvizky R; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Chanan-Khan AA; Multiple Myeloma Center, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA.
  • Ailawadhi S; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Brumm J; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Mundt KE; Genentech, Inc., South San Francisco, CA, USA.
  • Hong K; Genentech, Inc., South San Francisco, CA, USA.
  • McBride J; Genentech, Inc., South San Francisco, CA, USA.
  • Shon-Nguyen Q; Genentech, Inc., South San Francisco, CA, USA.
  • Xiao Y; Genentech, Inc., South San Francisco, CA, USA.
  • Ramakrishnan V; Genentech, Inc., South San Francisco, CA, USA.
  • Polson AG; Genentech, Inc., South San Francisco, CA, USA.
  • Samineni D; Genentech, Inc., South San Francisco, CA, USA.
  • Leipold D; Genentech, Inc., South San Francisco, CA, USA.
  • Humke EW; Genentech, Inc., South San Francisco, CA, USA.
  • McClellan JS; Genentech, Inc., South San Francisco, CA, USA.
  • Berdeja JG; Genentech, Inc., South San Francisco, CA, USA.
Blood Cancer J ; 9(2): 17, 2019 02 04.
Article em En | MEDLINE | ID: mdl-30718503
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Fc / Imunoconjugados / Antineoplásicos Imunológicos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Fc / Imunoconjugados / Antineoplásicos Imunológicos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article